Clinical utilities of aromatase inhibitors in breast cancer
Saranya Chumsri Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA Abstract: Aromatase is an enzyme that converts testosterones to estrogens. Inhibition of this enzyme has been shown to have several clinical utilities in breast cancer. Currently, there are three aro...
Main Author: | Chumsri S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-05-01
|
Series: | International Journal of Women's Health |
Online Access: | http://www.dovepress.com/clinical-utilities-of-aromatase-inhibitors-in-breast-cancer-peer-reviewed-article-IJWH |
Similar Items
-
AROMATASE INHIBITORS IN BREAST CANCER THERAPY
by: Hande Karahan, et al.
Published: (2011-04-01) -
Aromatase inhibitor strategies in metastatic breast cancer
by: Heather L McArthur, et al.
Published: (2009-07-01) -
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
by: Swaathi Jayaraman, et al.
Published: (2020-05-01) -
Bone health history in breast cancer patients on aromatase inhibitors.
by: Marilyn L Kwan, et al.
Published: (2014-01-01) -
Network-guided prediction of aromatase inhibitor response in breast cancer.
by: Matthew Ruffalo, et al.
Published: (2019-02-01)